ACHN:NSD-Achillion Pharmaceuticals, Inc (USD)

COMMON STOCK | Advertising Agencies | NSD

Last Closing Price

USD 110.00

Change

0.00 (0.00)%

Market Cap

USD 0.95B

Volume

30.00

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

ACHN Stock Forecast & Price:
Based on the Achillion Pharmaceuticals, Inc stock forecasts from 0 analysts, the average analyst target price for Achillion Pharmaceuticals, Inc is not available over the next 12 months. Achillion Pharmaceuticals, Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Achillion Pharmaceuticals, Inc is Very Bearish, which is based on 0 positive signals and 1 negative signals. At the last closing, Achillion Pharmaceuticals, Inc’s stock price was USD 110.00. Achillion Pharmaceuticals, Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +0.00% over the last year.

No recent analyst target price found for Achillion Pharmaceuticals, Inc
No recent average analyst rating found for Achillion Pharmaceuticals, Inc

About Achillion Pharmaceuticals, Inc (ACHN:NSD)

Achison Inc. focuses on operating online advertising business through www.dazhong368.com in the New York area, the United States. Its Website advertises various markets for professional individuals or companies, including real estate, services, accounting, and legal. The company ...Read More

Company Website : http://www.achillion.com

Address : 300 George Street 06511,New Haven,USA

Fiscal Year End : December

Currency: USD

Country : USA

Technical Indicators

Beta : 1.59

Shorted Shares : 8,603,331

200 Day Moving Average : 5.74

Shorted Shares Previous Month : 8,832,343

50 Day Moving Average : 6.76

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-06-29 )

Largest Industry Peers for Advertising Agencies

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CRTO Criteo Sa

+0.04 (+0.17%)

 USD1.47B 11.79 3.83
ADV Advantage Solutions Inc

-0.21 (-5.12%)

 USD1.31B 17.83 6.89
CMPR Cimpress NV

-0.60 (-1.50%)

 USD1.08B 46.32 10.24
CDLX Cardlytics Inc

-1.30 (-5.38%)

 USD0.92B N/A N/A
RUBI the Rubicon Project, Inc

N/A

 USD0.72B 14.80 104.00
TRMR Tremor International Ltd ADR

-0.31 (-3.53%)

 USD0.67B 9.66 2.87
QNST QuinStreet Inc

+0.09 (+0.92%)

 USD0.54B 192.35 24.64
MDCA MDC Partners Inc

N/A

 USD0.43B 0.90 18.76
ADTH AdTheorent Holding Company Inc

+0.28 (+11.20%)

 USD0.21B 22.31 18.55
INWK InnerWorkings, Inc

N/A

 USD0.16B 53.00 20.24

ETFs Containing ACHN

Symbol Name Weight Mer Price(Change) Market Cap

Market Performance

  Market Performance vs.
Industry/Classification (Advertising Agencies)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 2,296.51% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 2,296.51% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 585.36% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 585.36% N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 1,073.25% N/A N/A N/A N/A
Risk Adjusted Return 54.54% N/A N/A N/A N/A
Market Capitalization 0.95B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Advertising Agencies)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 4.36 N/A N/A N/A N/A
Price / Cash Flow Ratio -15.27 N/A N/A N/A N/A
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital -25.05% N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.59 N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date
New Post

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Negative cashflow

The company had negative total cash flow in the most recent four quarters.